Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3732018
Max Phase: Preclinical
Molecular Formula: C15H14Cl2N4O2
Molecular Weight: 353.21
Molecule Type: Small molecule
Associated Items:
ID: ALA3732018
Max Phase: Preclinical
Molecular Formula: C15H14Cl2N4O2
Molecular Weight: 353.21
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1cccc(NCC(=O)N/N=C/c2c(Cl)cncc2Cl)c1
Standard InChI: InChI=1S/C15H14Cl2N4O2/c1-23-11-4-2-3-10(5-11)19-9-15(22)21-20-6-12-13(16)7-18-8-14(12)17/h2-8,19H,9H2,1H3,(H,21,22)/b20-6+
Standard InChI Key: SKZTUPIPRLPDKY-CGOBSMCZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 353.21 | Molecular Weight (Monoisotopic): 352.0494 | AlogP: 2.96 | #Rotatable Bonds: 6 |
Polar Surface Area: 75.61 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 11.69 | CX Basic pKa: 1.69 | CX LogP: 2.09 | CX LogD: 2.09 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.62 | Np Likeness Score: -1.97 |
1. (2007) Hydrazide compounds, |
Source(1):